Teva to Present at the Upcoming Investor Conferences in March

PARSIPPANY, N.J. and TEL AVIV, Israel, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will participate in the upcoming investor conferences in March as follows:

• UBS European Healthcare Conference
  Tuesday, March 3, 2026 (investor meetings only – no webcast)
  
  
• Leerink Partners Global Healthcare Conference
  Monday, March 9, 2026, at 10:00 am ET (webcast fireside chat)
  
  
• Barclays 28
  th
  Annual Global Healthcare Conference
  Tuesday, March 10, 2026, at 8:00 am ET (webcast fireside chat)
  

Archived versions of the webcasts will be available within 24 hours after the end of the live discussion and will be accessible for up to 30 days.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health.

Teva Media Inquiries

Teva Investor Relations Inquires